RecensMedical Inc
394420
Company Profile
Business description
RecensMedical Inc is a specialized medical device company that provides precision cryotherapy and transdermal drug delivery solutions based on its independently developed cryogenic-thermoelectric combined rapid precision cooling technology platform. Its products include: TargetCool; and VetEase. Recense Medical's Rapid Precision Cooling Technology enables safe and effective cooling procedures by precisely controlling cooling temperatures at ultra-high speeds using patented cryogenic pressure control technology.
Contact
830 Dongtan Sunhwan-daero
Room 908, Yeongcheon-dong, Dongtan SK V1 Center
Gyeonggi-do
Hwaseong-si
KORT: +82 3180433036
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
55
Stocks News & Analysis
stocks
Eli Lilly receives FDA approval to add another oral GLP-1 to market
Wide moat Eli Lilly receives FDA approval for obesity pill.
stocks
Our top ASX picks in every sector
These companies are our favourite choices for investors wanting to boost Aussie equity exposure.
stocks
Which of the 3 giant AI IPOs should you buy?
OpenAI, Anthropic, and Databricks are expected to go public this year at massive valuations.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,774.90 | 124.80 | -1.40% |
| CAC 40 | 7,962.39 | 0.00 | 0.00% |
| DAX 40 | 23,168.08 | 130.81 | -0.56% |
| Dow JONES (US) | 46,504.67 | 61.07 | -0.13% |
| FTSE 100 | 10,436.29 | 71.50 | 0.69% |
| HKSE | 25,116.53 | 177.50 | -0.70% |
| NASDAQ | 21,879.18 | 38.23 | 0.18% |
| Nikkei 225 | 53,123.49 | 660.22 | 1.26% |
| NZX 50 Index | 12,902.15 | 76.28 | 0.59% |
| S&P 500 | 6,582.69 | 7.37 | 0.11% |
| S&P/ASX 200 | 8,579.50 | 105.50 | -1.21% |
| SSE Composite Index | 3,919.29 | 29.27 | -0.74% |